Economic evaluation of toripalimab combined with chemotherapy in the treatment of non-small cell lung cancer

HIGHLIGHTS

• who: ufeffHaoufeff ufeffWangufeff et al. from the Innsbruck Medical University, Austria have published the research work: Economic evaluation of toripalimab combined with chemotherapy in the treatment of non-small cell lung cancer, in the Journal: (JOURNAL)
• what: One-way sensitivity analysis was conducted to evaluate the impact of changes in a single parameter on the results, while PSA was applied to simulate the impact of changes in multiple parameters at the same time. This study intended to set the variation range of important parameters in the model, such as relevant cost value, health utility value . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.